|
Market Closed -
Xetra
11:35:29 2026-08-14 EDT
|
5-day change | 1st Jan Change | ||
| 4.780 EUR | +1.70% |
|
+11.16% | +29.19% |
Company Valuation: MEDICLIN AG
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 186.2 | 171 | 130.2 | 115 | 175.8 | 227 | - | - |
| Change | - | -8.16% | -23.89% | -11.68% | 52.89% | 29.19% | - | - |
| Enterprise Value (EV) | 186.2 | 171 | 130.2 | 115 | 175.8 | 227 | 227 | 227 |
| Change | - | -8.16% | -23.89% | -11.68% | 52.89% | 29.19% | 0% | 0% |
| P/E | - | - | - | - | - | - | - | - |
| PBR | 1.02x | 0.82x | 0.66x | 0.52x | 0.71x | 0.8x | 0.71x | 0.63x |
| PEG | - | - | - | - | - | - | - | - |
| Capitalization / Revenue | 0.28x | 0.24x | 0.18x | 0.15x | 0.22x | 0.29x | 0.28x | 0.28x |
| EV / Revenue | 0x | 0x | 0x | 0x | 0x | 0.29x | 0.28x | 0.28x |
| EV / EBITDA | 0x | 0x | 0x | 0x | 0x | 1.99x | 1.97x | 1.96x |
| EV / EBIT | 0x | 0x | 0x | 0x | 0x | 3.66x | 3.63x | 3.62x |
| EV / FCF | - | - | - | - | - | - | - | - |
| FCF Yield | - | - | - | - | - | - | - | - |
| Dividend per Share 2 | - | - | - | - | 0.04 | 0.04 | 0.04 | 0.04 |
| Rate of return | - | - | - | - | 1.08% | 0.84% | 0.84% | 0.84% |
| EPS 2 | - | - | - | - | - | - | - | - |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 673.1 | 704.7 | 730.1 | 748.8 | 784.5 | 787.5 | 803.2 | 819.3 |
| EBITDA 1 | 85.22 | 90.92 | 98.73 | 103.8 | 115.6 | 114.3 | 115.3 | 115.6 |
| EBIT 1 | 11.56 | 19.52 | 12.72 | 53.49 | 55.36 | 62.11 | 62.47 | 62.72 |
| Net income 1 | 1.461 | 9.441 | -10.78 | 24.84 | 25.49 | 36.66 | 38.2 | 40.12 |
| Net Debt | - | - | - | - | - | - | - | - |
| Reference price 2 | 3.920 | 3.600 | 2.740 | 2.420 | 3.700 | 4.780 | 4.780 | 4.780 |
| Nbr of stocks (in thousands) | 47,500 | 47,500 | 47,500 | 47,500 | 47,500 | 47,500 | - | - |
| Announcement Date | 3/30/22 | 3/31/23 | 3/27/24 | 3/28/25 | 3/27/26 | - | - | - |
1EUR in Million2EUR
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
| - | - | - | 0.84% | 263M | ||
| 31.63x | 3.01x | 13.49x | 1.37% | 17.73B | ||
| 51.96x | 4.44x | 28.96x | 0.27% | 13.41B | ||
| 19.4x | 2.3x | 10.73x | 0.64% | 12.19B | ||
| 22.35x | 3.14x | 11.2x | 1.92% | 11.97B | ||
| 25.73x | 2.07x | 16.72x | 0.15% | 10.5B | ||
| 85.17x | 7.4x | 28.64x | - | 9.72B | ||
| 19.15x | 2.79x | 11.51x | 4.17% | 9.36B | ||
| 53.77x | 6.79x | 29.36x | 0.14% | 7.33B | ||
| 34.21x | 0.94x | 7.83x | 1.89% | 7.31B | ||
| Average | 38.15x | 3.65x | 17.61x | 1.27% | 9.98B | |
| Weighted average by Cap. | 37.01x | 3.57x | 17.35x | 1.27% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- MED Stock
- Valuation MEDICLIN AG
Select your edition
All financial news and data tailored to specific country editions
















